Harmony Biosciences Acquires Epygenix Therapeutics, Inc., Adding Late-Stage Epilepsy Franchise to Growing Pipeline of Innovative CNS Assets
Go back to Harmony Biosciences Acquires Epygenix Therapeutics, Inc., Adding Late-Stage Epilepsy Franchise to Growing Pipeline of Innovative CNS Assets| Harmony Metals, Inc. Common (NASDAQ: HRMY) | Delayed: 42.02 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $42.02 | 52 Week High | $1.35 | |||
| Open | $42.02 | 52 Week Low | $0.10 | |||
| Day High | $42.02 | P/E | N/A | |||
| Day Low | $42.02 | EPS | $0.00 | |||
| Volume | 254 | |||||
